OGN - Company ID 0001821825
The table below shows Organon & Co.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $1.46B | $1.60B | $1.59B | $1.51B | $1.58B | $1.61B |
| Cost of revenue | $677.00M | $745.00M | $720.00M | $672.00M | $659.00M | $668.00M |
| Gross profit | $783.00M | $857.00M | $874.00M | $841.00M | $923.00M | $939.00M |
| R&D | - | - | - | - | - | - |
Organon & Co. reported annual revenue of $6.22B for fiscal year 2025. That is down 2.9% from $6.40B in fiscal 2024. Over the 7 fiscal years shown, annual revenue declined from $7.78B (FY 2019) to $6.22B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $424.00M |
| $415.00M |
| $453.00M |
| $420.00M |
| $422.00M |
| $437.00M |
| Operating income | - | - | - | - | - | - |
| Income tax | $67.00M | $83.00M | $84.00M | $14.00M | -$152.00M | $40.00M |
| Net income | $146.00M | $160.00M | $145.00M | $87.00M | $359.00M | $195.00M |
| EPS (diluted) | $0.55 | $0.61 | $0.56 | $0.33 | $1.38 | $0.75 |